Results 1 to 10 of about 190,274 (201)

Doxorubicin for treatment of histiocytic sarcoma in dogs: 31 cases (2003–2017) [PDF]

Journal of the American Veterinary Medical Association, 2022
OBJECTIVE To evaluate the efficacy of doxorubicin for treatment of histiocytic sarcoma (HS) in dogs, whether administered as the sole treatment or as an adjunct to surgery or radiation therapy.
Rhiannon M. Doka, Steven E. Suter, Michael Mastromauro, Ashley Bennett, Paul R. Hess   +4 more
openalex   +2 more sources

Near Complete Response to Trametinib Treatment in Histiocytic Sarcoma Harboring a Somatic KRAS Mutation [PDF]

The Journal of the National Comprehensive Cancer Network, 2022
Survival outcomes of patients with histiocytic neoplasms are poor, with no standard-of-care treatments available for these malignancies. Recent characterization of the genomic landscape of various histiocytic neoplasms have shown a predominance of ...
Boyu Hu, Jay Patel, Randa Tao, Richard B. Cannon, Marcus M. Monroe, Gaurav Goyal   +5 more
openalex   +2 more sources

Epidemiology and Survival of Dogs Diagnosed with Splenic Lymphoid Hyperplasia, Complex Hyperplasia, Stromal Sarcoma and Histiocytic Sarcoma

Animals, 2022
Canine splenic fibrohistiocytic nodules traditionally encompassed benign lymphoid hyperplasia, complex hyperplasia, and malignant fibrous histiocytoma. The latter has been recently re-classified into histiocytic sarcoma and stromal sarcoma.
Cleide H. Spröhnle-Barrera, Jayne McGhie, Rachel E. Allavena, Helen C. Owen, Chiara Palmieri, Tamsin S. Barnes   +5 more
doaj   +2 more sources

Enhanced Computed Tomography and ¹⁸F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Uncommon Histiocytic Sarcoma of Small Intestine Arising after Gastric Large B-Cell Lymphoma

Diagnostics, 2023
Histiocytic sarcoma (HS) is an extremely rare and aggressive malignant neoplasm of hematopoietic origin that shows morphologic and immunophenotypic evidence of histiocytic differentiation.
Miju Cheon, Jang Yoo, Hae Su Kim, Miji Lee   +3 more
doaj   +2 more sources

Histiocytic Sarcoma [PDF]

Definitions, 2020
Histiocytic sarcoma, a rare malignant neoplasm showing morphologic and immunophenotypic features of histiocytes, is characterized typically by extranodal presentation and a dismal clinical course, particularly in patients with disseminated disease.
National Cancer Institute
openalex   +2 more sources

Successful Treatment of Central Nervous System Histiocytic Sarcoma With Craniectomy and Adjuvant Radiotherapy [PDF]

Cureus, 2022
Histiocytic sarcoma (HS) is a rare, aggressive non-Langerhans histiocytic cell neoplasm of hematopoietic origin. Histiocytic sarcoma is prone to early systemic metastasis, rendering early diagnosis and treatment critical determinants for patient outcome.
Soroush Shahrokh, Afshin Rakhsha, Mohadeseh Shahin, Amir Javadzadegan, Mahsa Ahadi, Samira Azghandi, Farzad Taghizadeh‐Hesary   +6 more
openalex   +2 more sources

Primary pulmonary histiocytic sarcoma with high PD‐L1 expression benefited from immunotherapy: A case report and bioinformatic analysis

The Clinical Respiratory Journal
Histiocytic sarcoma is an aggressive haematopoietic malignancy accounting for less than 1% of haematolymphoid neoplasms with a diagnosis based on morphology and immunophenotype of tissue biopsies with a very poor prognosis.
Yuanjie Lin, Qian Cao, Aonan Hong, Xiao Liang   +3 more
doaj   +2 more sources

Periarticular histiocytic sarcoma in a French Bulldog [PDF]

Brazilian Journal of Veterinary Pathology
Histiocytic sarcoma is a neoplasm originating from the dendritic cell lineage and presents an aggressive biological behavior and poor prognosis due to its increased metastatic rate.
Mayra Cunha Flecher, Nathalia Teixeira Nascimento, Marina Possa dos Reys, Leonardo Lima Gorza, Mayara de Souza, Rodrigo dos Santos Horta   +5 more
openalex   +2 more sources

Primary splenic histiocytic sarcoma associated with hemophagocytic lymphohistiocytosis: A case report and review of literature of next‐generation sequencing involving FLT3, NOTCH2, and KMT2A mutations

Cancer Reports, 2022
Background Histiocytic sarcoma is a very rare monocyte/macrophage‐derived hematopoietic system tumor with a poor prognosis whose diagnosis is pathologically challenging due to its extreme rarity and histological overlap with various mimicking entities in
Nelson Montalvo, Jorge Lara‐Endara, Ligia Redrobán, María Leiva, Christian Armijos, Leonardo Russo   +5 more
doaj   +2 more sources

A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab

International Cancer Conference Journal, 2022
Yu Furui, Takashi Kurata, Kazutoshi Komori, Eriko Uchida, Yosuke Miyairi, Akihiro Chiba, Yoshifumi Ogiso, Kazuo Sakashita   +7 more
openalex   +3 more sources